#avycaz

All The Most Important Pharmaceutical News Stories Of The Week – February 2018 – Week #1 Amgen Receives CHMP Positive Opinion to Add Updated Overall Survival Data to KYPROLIS® (carfilzomib) Label

  January 30, 2018

Amgen has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending a label variation…

Bandage Turns Green to Signal Infection

Image Courtesy: link: http://www.gadgetpronew.com/2015/12/smart-bandage-signals-infection-by.html%3Fm%3D0 author: gadgetpronew.com description: Smart Bandage Signals C O N T E N T S: KEY TOPICS Bacterial infection is a fairly common and potentially dangerous complication of wound healing, but a new “intelligent” dressing that turns fluorescent green to signal the onset of an infection could…

Antibiotic Resistance in the US

Centers for Disease Control and Prevention (CDC) ANTIBIOTIC RESISTANCE THREATS in the United States

2013

Facts about Antibiotic Resistance

Antibiotic resistance has been called one of the world’s most pressing public health problems.

Every time a person takes antibiotics, sensitive bacteria are killed, but resistant ones may be left to grow and multiply.

Repeated and improper uses of antibiotics…

Drug Safety Communication – Dose Confusion and Medication Errors

Avycaz (ceftazidime and avibactam)

[pullquote align=”right”][adrotate banner=”7″][/pullquote]

Antibacterial Drug for Risk of Dosing Errors

FDA is warning health care professionals about the risk for dosing errors with the intravenous antibacterial drug Avycaz (ceftazidime and avibactam) due to confusion about the drug strength displayed on the vial and carton labels. Avycaz was initially approved…